Extracorporeal immunoadsorption for the specific removal of lipoprotein (a) (Lp(a) apheresis): preliminary clinical data
- 31 January 1994
- journal article
- clinical trial
- Published by Elsevier in Chemistry and Physics of Lipids
- Vol. 67-68, 323-330
- https://doi.org/10.1016/0009-3084(94)90153-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Lipoprotein (a) in Heart DiseaseScientific American, 1992
- Effect of HELP‐LDL‐apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post‐treatment return to baseline levelsEuropean Journal of Clinical Investigation, 1989
- Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients.Circulation, 1988
- Long-term application of three types of sorbents for LDL-apheresisPlasma Therapy and Transfusion Technology, 1988
- The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosisDependence on serum LDL levelsAtherosclerosis, 1986
- Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.Circulation, 1986
- Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarctionAtherosclerosis, 1986
- Levels of lipoprotein Lp(a) decline with neomycin and niacin treatmentAtherosclerosis, 1985
- Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozololBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Lipoprotein Lp(a) and the risk for myocardial infarctionAtherosclerosis, 1981